Please login to the form below

Not currently logged in
Email:
Password:

ABPI names latest Code breaches

Bayer Healthcare, Chiesi and Eli Lilly and Company have been called out for breaches of the Association of the British Pharmaceutical Industry's Code of Practice, while Bayer Schering Pharma has been publicly reprimanded

Bayer Healthcare, Chiesi and Eli Lilly and Company have been named in advertisements for breaches of the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice, while Bayer Schering Pharma has been publicly reprimanded.

Bayer Healthcare, Chiesi, Eli Lilly were found to have breached Clause 2 of the ABPI Code of Practice - administered by the Prescription Medicines Code of Practice Authority (PMCPA) - bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Meanwhile Bayer Schering Pharma has been reprimanded for failing to include prescribing information.

The breaches will be highlighted in advertisements in the medical, pharmaceutical and nursing press.

The PMCPA May Code of Practice Review (PDF) has further information on the breaches of the Code.

31st May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics